Scripps-eMed Covid-19 Study: A Prospective Monitoring Study for Those Individuals Treated With Paxlovid
NCT05618600 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 917
Last updated 2026-04-24
Summary
A prospective monitoring study for those individuals treated with Paxlovid
Conditions
Sponsors & Collaborators
-
eMed
collaborator UNKNOWN -
Scripps Translational Science Institute
lead OTHER
Principal Investigators
-
Jay Pandit, MD · Scripps Research Institute
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-08-04
- Primary Completion
- 2023-12-08
- Completion
- 2024-06-10
Countries
- United States
Study Locations
More Related Trials
-
A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of COVID-19 But Are Not Hospitalized
NCT05799495 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare the Efficacy of GNS561 Versus Standard of Care in Patients With SARS-CoV-2 (COVID-19) Infection
NCT04637828 ·Status: UNKNOWN ·Phase: PHASE2
-
RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms
NCT05595369 ·Status: COMPLETED ·Phase: PHASE2
-
RECOVER-VITAL: Platform Protocol, Appendix to Measure the Effects of Paxlovid on Long COVID Symptoms
NCT05965726 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Chance of Getting Severe COVID-19
NCT05890612 ·Status: RECRUITING
-
A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.
NCT07261085 ·Status: ACTIVE_NOT_RECRUITING
-
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
NCT04960202 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Defibrotide for the Treatment of Severe COVID-19
NCT04652115 ·Status: RECRUITING ·Phase: PHASE2
-
A Simple Approach to Treat COVID-19 Patients at Home.
NCT04794998 ·Status: COMPLETED
-
Effectiveness and Safety of New Oral Antivirals for COVID-19
NCT05894603 ·Status: UNKNOWN
-
A Registry Study of Patients Hospitalized With Confirmed COVID-19
NCT05792865 ·Status: UNKNOWN
-
Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and Older
NCT04798027 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Paxlovid for Treatment of Long Covid
NCT05576662 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care
NCT05195749 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in People 12 Years Old or Older With Return of COVID-19 Symptoms and SARS-CoV-2 Positivity After Finishing Treatment With Nirmatrelvir/Ritonavir
NCT05567952 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness
NCT05603143 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19
NCT07089680 ·Status: NOT_YET_RECRUITING
-
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19
NCT05386472 ·Status: TERMINATED ·Phase: PHASE1
-
A Decentralized, Randomized Phase 2 Efficacy and Safety Study of Nirmatrelvir/Ritonavir in Adults with Long COVID.
NCT05668091 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy of IN STI-9199 in Treating Symptomatic COVID-19 in Outpatient Adults and Adolescents
NCT05372783 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.
NCT04847622 ·Status: COMPLETED
-
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
NCT05261139 ·Status: RECRUITING ·Phase: PHASE3
-
Efficiency and Safety of Paxlovid for COVID-19 Patients With Severe Chronic Kidney Disease
NCT05938140 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.
NCT07090486 ·Status: COMPLETED